For Harpoon Therapeutics Inc. [HARP], Analyst sees a rise to $31. What next?
Edison Baldwin March 8, 2021 Harpoon Therapeutics Inc. [NASDAQ: HARP] surged by $2.04 during the normal trading session on Friday and reaching a high of $25.00 during the day while it closed the day at $23.40. The company report on January 13, 2021 that Harpoon Therapeutics Granted Orphan Drug Designation from FDA for HPN217 for Treatment of Multiple Myeloma. Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for H...